Exercise and biomarkers for cancer prevention studies

Journal of Nutrition

Volumn 137, Issue 1, 2007, Pages

  Campbell, Kristin L ^a   McTiernan, Anne ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; AMYLOID A PROTEIN; ANTIANDROGEN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; ESTROGEN; INTERLEUKIN 6; PROGESTERONE; SEX HORMONE; SOMATOMEDIN; TUMOR NECROSIS FACTOR ALPHA;

AEROBIC EXERCISE; BREAST CANCER; CANCER PREVENTION; CANCER RISK; CELL PROLIFERATION; CLINICAL TRIAL; COLON CANCER; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; ESOPHAGUS CANCER; ESTROGEN BLOOD LEVEL; HEALTH PROGRAM; HUMAN; HYPERINSULINEMIA; IMMUNE RESPONSE; INFLAMMATION; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; LOW FAT DIET; OBESITY; PHYSICAL ACTIVITY; POSTMENOPAUSE; PROGESTERONE BLOOD LEVEL; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; WEIGHT REDUCTION;

EID: 33846074397     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/137.1.161s     Document Type: Conference Paper

References (148)

1. Vainio H, Bianchini F., eds. Weight Control and Physical Activity. Lyon: IARC Press; 2002.
2. Centers for Disease Control and Prevention (CDC). Behavioral risk factors surveillance systems survey data. Atlanta, Georgia: US Department of Health and Human Services. [updated 2004 Dec 23; cited 2006 Aug 4]. Available from: http://apps.nccd.cdc.gov/brfss/Trends/TrendData.asp/.
3. McTiernan A, Ulrich C, Slate S, Potter J. Physical activity and cancer etiology: associations and mechanisms. Cancer Causes Control. 1998;9:487-509.
4. Friedenreich CM, Thune I, Brinton LA, Albanes D. Epidemiologic issues related to the association between physical activity and breast cancer. Cancer. 1998;83:600-10.
5. Hoffman-Goetz L, Apter D, Demark-Wahnefried W, Goran M, McTiernan A, Reichman M. Possible mechanisms mediating an association between physical activity and breast cancer. Cancer. 1998;83:621-8.
6. Rundle A. Molecular epidemiology of physical activity and cancer. Cancer Epidemiol Biomarkers Prev. 2005;14:227-36.
7. Key T, Appleby P, Barnes I, Reeves G; Endogenous Hormones and Breast Cancer Collaboration Group. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst. 2002;94:606-16.
8. Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev. 2002;11:1531-43.
9. Tammela T. Endocrine treatment of prostate cancer. J Steroid Biochem Mol Biol. 2004;92:287-95.
10. Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, Lieber MM, Cespedes RD, Atkins JN, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003;349:215-24.
11. Bernstein L, Henderston BE, Hanisch R, Sullivan-Halley J, Ross RK. Physical exercise and reduced risk of breast cancer in young women. J Natl Cancer Inst. 1994;86:1403-8.
12. Bullen BA, Skrinar GS, Beitins IZ, Carr DB, Reppert SM, Dotson CO, Fencl MD, Gervino EV, McArthur JW. Endurance training effects on plasma hormonal responsiveness and sex hormone excretion. J Appl Physiol. 1984;56:1453-63.
13. Keizer HA, Kuipers H, de Haan J, Janssen GM, Beckers E, Habets L, van Kranenburg G, Geurten P. Effect of a 3-month endurance training program on metabolic and multiple hormonal responses to exercise. Int J Sports Med. 1987;8 Suppl 3:154-60.
14. Bullen BA, Skrinar GS, Beitins IZ, Von Mering G, Turnbull BA, McArthur JW. Induction of menstrual disorders by strenuous exercise in untrained women. N Engl J Med. 1985;312:1349-53.
15. Loucks AB. Energy availability, not body fatness, regulated reproductive function in women. Exerc Sport Sci Rev. 2003;31:144-8.
16. Loucks AB, Redman LM. The effect of stress on menstrual function. Trends Endocrinol Metab. 2004;15:466-71.
17. Williams NI, Helmreich DL, Parfitt DB, Caston-Balderrama A, Cameron JL. Evidence for a causal role of low energy availability in the induction of menstrual cycle disturbances during strenuous exercise training. J Clin Endocrinol Metab. 2001;86:5184-93.
18. Bernstein L, Ross R, Lobo RA, Hanische R, Krailo MD, Henderson BE. The effects of moderate physical activity on menstrual cycle patterns in adolescence: Implications for breast cancer prevention. Br J Cancer. 1987;55:681-5.
19. Broocks A, Pirke KM, Schweiger U, Tuschl RJ, Laessle RG, Strowitzki T, Horl E, Horl T, Haas W, Jeschke D. Cyclic ovarian function in recreational athletes. J Appl Physiol. 1990;68:2083-6.
20. De Souza MJ, Miller BE, Loucks AB, Luciano AA, Pescatello LS, Campbell CG, Lasley BL. High frequency of luteal phase deficiency and anovulation in recreational women runners: Blunted elevation in follicle-stimulating hormone observed during luteal-follicular transition. J Clin Endocrinol Metab. 1998;83:4220-32.
21. Baker E, Demers L. Menstrual status in female athletes: correlation with reproductive hormones and bone density. Obstet Gynecol. 1988;72:683-7.
22. Pirke KM, Schweiger U, Broocks A, Tuschl RJ, Laessle RG. Luteinizing hormone and follicle stimulating hormone secretion patterns in female athletes with and without menstrual disturbances. Clin Endocrinol (Oxf). 1990;33:345-53.
23. Schweiger U, Laessle R, Schweiger M, Herrmann F, Riedel W, Pirke KM. Caloric intake, stress, and menstrual function in athletes. Fertil Steril. 1988;49:447-50.
24. Ronkainen H. Depressed follicle-stimulating hormone, luteinizing hormone, and prolactin responses to the luteinizing hormone-releasing hormone thyrotropin-releasing hormone, and metoclopramide test in endurance runners in the hard-training season. Fertil Steril. 1985;44:755-9.
25. Ellison PT, Lager C. Moderate recreational running is associated with lowered saliva progesterone profiles in women. Am J Obstet Gynecol. 1986;154:1000-3.
26. McTiernan A. Physical activity effects on sex hormones. In: McTiernan, A., editor. Cancer prevention and management through exercise and weight control. Boca Raton: CRC Press.
27. Bonen A. Recreational exercise does not impair menstrual cycles: A prospective study. Int J Sports Med. 1992;13:110-20.
28. Rogol AD, Weltman A, Weltman JY, Seip RL, Snead DB, Levine S, Haskvitz EM, Thompson DL, Schurrer R, et al. Durability of the reproductive axis in eumenorrheic women during 1 yr of endurance training. J Appl Physiol. 1992;72:1571-80.
29. Cauley JA, Gutai JP, Kuller LH, LeDonne D, Powell JG. The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol. 1989;129:1120-31.
30. McTiernan A, Wu L, Chen C, Chlebowski RT, Mossavar-Rahmani Y, Modugno F, Perri MG, Stanczyk FZ, Van Horn L, Investigaotrs WHI. Relation of BMI and physical activity to sex hormones in postmenopausal women. Obesity (Silver Spring). 2006;14:1662-77.
31. Verkasalo PK, Thomas HV, Appleby PN, Davey GK, Key TJ. Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom). Cancer Causes Control. 2001;12:47-59.
32. Key TJ, Allen NE, Verkasalo PK, Banks E. Energy balance and cancer: the role of sex hormones. Proc Nutr Soc. 2001;60:81-9.
33. Howard BV, Manson JE, Stefanick ML, Beresford SA, Frank G, Jones B, Rodabough RJ, Snetselaar L, Thomson C, et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA. 2006;295:39-49.
34. Hackney AC, Moore AW, Brownlee KK. Testosterone and endurance exercise: development of the "exercise-hypogonadal male condition7quot;. Acta Physiol Hung. 2005;92:121-37.
35. Hackney AC, Szczepanowska E, Viru AM. Basal testicular testosterone production in endurance-trained men is suppressed. Eur J Appl Physiol. 2003;89:198-201.
36. Hackney AC, Fahrner CL, Gulledge TP. Basal reproductive hormonal profiles are altered in endurance trained men. J Sports Med Phys Fitness. 1998;38:138-41.
37. De Souza MJ, Miller BE. The effect of endurance training on reproductive function in male runners. A 'volume threshold' hypothesis. Sports Med. 1997;23:357-74.
38. Friedenreich CM. Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev. 2001;10:15-32.
39. Carmichael AR, Bates T. Obesity and breast cancer: a review of the literature. Breast. 2004;13:85-92.
40. Morimoto LM, White E, Chen Z, Chlebowski RT, Hays J, Kuller L, Lopez AM, Manson J, Margolis KL, et al. Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Control. 2002;13:741-51.
41. Meilahn EN, De Stavola B, Allen DS, Fentiman I, Bradlow HL, Sepkovic DW, Kuller LH. Do urinary oestrogen metabolites predict breast cancer? Br J Cancer. 1998;78:1250-5.
42. Muti P, Bradlow HL, Micheli A, Krogh V, Freudenheim JL, Schunemann HJ, Stanulla M, Yang J, Sepkovic DW, et al. Estrogen metabolism and risk of breast cancer: a prospective study of 2:16alpha hydroxyestrone ratio in premenopausal and postmenopausal women. Epidemiology. 2000;11:635-40.
43. Wellejus A, Olsen A, Tjonneland A, Thomsen BL, Overvad K, Loft S. Urinary hydroxyestrogens and breast cancer risk among postmenopausal women: a prospective study. Cancer Epidemiol Biomarkers Prev. 2005;14:2137-42.
44. Russell JB, Mitchell DE, Musey PI, Collins DC. The relationship of exercise to anovluatory cycles in female athletes: hormonal and physical characteristics. Obstet Gynecol. 1984;63:452-6.
45. Russell JB, Mitchell DE, Musey PI, Collins DC. The role of beta-endorphins and catechol estrogens on the hypothalamic-pituitary axis in female athletes. Fertil Steril. 1984;42:690-5.
46. Snow RC, Barbiebi RL, Frisch RE. Estrogen 2-hydroxylase oxidation and menstrual function among elite oarswomen. J Clin Endocrinol Metab. 1989;69:369-76.
47. Bentz AT, Schneider CM, Westerlind KC. The relationship between physical activity and 2-hydroxyestrone, 16alpha-hydroxyestrone, and the 2/16 ratio in premenopausal women (United States). Cancer Causes Control. 2005;16:455-61.
48. Matthews CE, Fowke JH, Dai Q, Bradlow HL, Jin F, Shu XO, Goa YT, Longcope C, Hebert JR, Zheng W. Physical activity, body size, and estrogen metabolism in women. Cancer Causes Control. 2004;15:473-81.
49. Campbell KL, Westerlind KC, Harber VJ, Friedenreich CM, Courneya KS. Associations between aerobic fitness and estrogen metabolites in premenopausal women. Med Sci Sports Exerc. 2005;37:585-92.
50. Atkinson C, Lampe JW, Tworoger SS, Ulrich CM, Bowen D, Irwin ML, Schwartz RS, Rajan BK, Yasui Y, et al. Effects of a moderate intensity exercise intervention on estrogen metabolism in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2004;13:868-74.
51. Pasagian-Macaulay A, Meilahn EN, Bradlow HL, Sepkovic DW, Buhari AM, Simkin-Silverman L, Wing RR, Kuller LH. Urinary markers of estrogen metabolism 2- and 16 alpha-hydroxylation in premenopausal women. Steroids. 1996;61:461-7.
52. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-9.
53. Kaaks R, Lukanova A. Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc Nutr Soc. 2001;60:91-106.
54. Frank LL. Exercise and insulin resistance. In McTiernan, A., editor. Cancer prevention and management through exercise and weight control. Boca Raton: CRC Press.
55. Hu FB, Manson JE, Liu S, Hunter D, Colditz GA, Michels KB, Speizer FE, Giovannucci E. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst. 1999;91:542-7.
56. Saydah SH, Platz EA, Rifai N, Pollak MN, Brancati FL, Helzlsouer KJ. Association of markers of insulin and glucose control with subsequent colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2003;12:412-8.
57. Saydah SH, Loria CM, Eberhardt MS, Brancati FL. Abnormal glucose tolerance and the risk of cancer death in the United States. Am J Epidemiol. 2003;157:1092-100.
58. Wilmore J, Costill D. Physiology of sport and exercise. Champaign, IL: Human Kinetics.
59. Mikines KJ, Sonne B, Tronier B, Galbo H. Effects of acute exercise and detraining on insulin action in trained men. J Appl Physiol. 1989;66:704-11.
60. Henriksson J. Influence of exercise on insulin sensitivity. J Cardiovasc Risk. 1995;2:303-9.
61. Regensteiner JG, Mayer EJ, Shetterly SM, Eckel RH, Haskell WL, Marshall JA, Baxter J, Hamman RF. Relationship between habitual physical activity and insulin levels among nondiabetic men and women. San Luis Valley Diabetes Study. Diabetes Care. 1991;14:1066-74.
62. Regensteiner JG, Shetterly SM, Mayer EJ, Eckel RH, Haskell WL, Baxter J, Hamman RF. Relationship between habitual physical activity and insulin area among individuals with impaired glucose tolerance. The San Luis Valley Diabetes Study. Diabetes Care. 1995;18:490-7.
63. DiPietro L, Dziura J, Yeckel CW, Neufer PD. Exercise and improved insulin sensitivity in older women: evidence of the enduring benefits of higher intensity training. J Appl Physiol. 2006;100:142-9.
64. Duncan GE, Perri MG, Theriaque DW, Hutson AD, Eckel RH, Stacpoole PW. Exercise training, without weight loss, increases insulin sensitivity and postheparin plasma lipase activity in previously sedentary adults. Diabetes Care. 2003;26:557-62.
65. DiPietro L, Seeman TE, Stachenfeld NS, Katz LD, Nadel ER. Moderate-intensity aerobic training improves glucose tolerance in aging independent of abdominal adiposity. J Am Geriatr Soc. 1998;46:875-9.
66. Boule NG, Haddad E, Kenny GP, Wells GA, Sigal RJ. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA. 2001;286:1218-27.
67. Ivy JL. Role of exercise training in the prevention and treatment of insulin resistance and non-insulin-dependent diabetes mellitus. Sports Med. 1997;24:321-36.
68. Poehlman ET, Dvorak RV, DeNino WF, Brochu M, Ades PA. Effects of resistance training and endurance training on insulin sensitivity in nonobese, young women: a controlled randomized trial. J Clin Endocrinol Metab. 2000;85:2463-8.
69. Shaibi GQ, Cruz ML, Ball GD, Weigensberg MJ, Salem GJ, Crespo NC, Goran MI. Effects of resistance training on insulin sensitivity in overweight Latino adolescent males. Med Sci Sports Exerc. 2006;38:1208-15.
70. Matsuzawa Y, Shimomura I, Nakamura T, Keno Y, Kotani K, Tokunaga K. Pathophysiology and pathogenesis of visceral fat obesity. Obes Res. 1995;3: Suppl 2:187S-94S.
71. Ross R, Dagnone D, Jones PJ, Smith H, Paddags A, Hudson R, Janssen I. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med. 2000;133:92-103.
72. Ross R, Janssen I, Dawson J, Kungl AM, Kuk JL, Wong SL, Nguyen-Duy TB, Lee S, Kilpatrick K, Hudson R. Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial. Obes Res. 2004;12:789-98.
73. Yu H, Rohan TE. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst. 2000;92:1472-89.
74. Pollak MN, Schernhammer ES, Hankinson SE. Insulin-like growth factors and neoplasia. Nat Rev Cancer. 2004;4:505-18.
75. Schernhammer ES, Holly JM, Hunter DJ, Pollak MN, Hankinson SE. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II. Endocr Relat Cancer. 2006;13:583-92.
76. Schernhammer ES, Holly JM, Pollak MN, Hankinson SE. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2005;14:699-704.
77. Rollison DE, Newschaffer CJ, Tao Y, Pollak M, Helzlsouer KJ. Premenopausal levels of circulating insulin-like growth factor I and the risk of postmenopausal breast cancer. Int J Cancer. 2006;118:1279-84.
78. Orenstein MR, Friedenreich CM. Review of physical activity and the IGF family. JPAH. 2004;1:291-320.
79. Balkwill F, Coussens LM. Cancer: an inflammatory link. Nature. 2004;431:405-6.
80. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357:539-45.
81. Kelesidis I, Kelesidis T, Mantzoros CS. Adiponectin and cancer: a systematic review. Br J Cancer. 2006;94:1221-5.
82. Biancari F, Lahtinen J, Lepojarvi S, Rainio P, Salmela E, Pokela R, Lepojarvi M, Satta J, Juvonen TS. Preoperative C-reactive protein and outcome after coronary artery bypass surgery. Ann Thorac Surg. 2003;76:2007-12.
83. Lehrer S, Diamond EJ, Mamkine B, Droller MJ, Stone NN, Stock RG. C-reactive protein is significantly associated with prostate-specific antigen and metastatic disease in prostate cancer. BJU Int. 2005;95:961-2.
84. Wetmore CM, Ulrich CM. Mechanisms associating physical activity with cancer incidence: exercise and immune function. In: McTiernan, A., editor. Cancer Prevention and Management through Exercise and Weight Control. Boca Raton: CRC Taylor Francis.
85. Marcell TJ, McAuley KA, Traustadottir T, Reaven PD. Exercise training is not associated with improved levels of C-reactive protein or adiponectin. Metabolism. 2005;54:533-41.
86. Rohde LE, Hennekens CH, Ridker PM. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men. Am J Cardiol. 1999;84:1018-22.
87. Taaffe DR, Harris TB, Ferrucci L, Rowe J, Seeman TE. Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. J Gerontol A Biol Sci Med Sci. 2000;55:M709-715.
88. Geffken DF, Cushman M, Burke GL, Polak JF, Sakkinen PA, Tracy RP. Association between physical activity and markers of inflammation in a healthy elderly population. Am J Epidemiol. 2001;153:242-50.
89. Church TS, Barlow CE, Earnest CP, Kampert JB, Priest EL, Blair SN. Associations between cardiorespiratory fitness and C-reactive protein in men. Arterioscler Thromb Vasc Biol. 2002;22:1869-76.
90. Ford ES. Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults. Epidemiology. 2002;13:561-8.
91. Rothenbacher D, Hoffmeister A, Brenner H, Koenig W. Physical activity, coronary heart disease, and inflammatory response. Arch Intern Med. 2003;163:1200-5.
92. LaMonte MJ, Durstine JL, Yanowitz FG, Lim T, DuBose KD, Davis P, Ainsworth BE. Cardiorespiratory fitness and C-reactive protein among a tri-ethnic sample of women. Circulation. 2002;106:403-6.
93. Pitsavos C, Panagiotakos DB, Chrysohoou C, Kavouras S, Stefanadis C. The associations between physical activity, inflammation, and coagulation markers, in people with metabolic syndrome: the ATTICA study. Eur J Cardiovasc Prev Rehabil. 2005;12:151-8.
94. Reuben DB, Judd-Hamilton L, Harris TB, Seeman TE. The associations between physical activity and inflammatory markers in high-functioning older persons: MacArthur Studies of Successful Aging. J Am Geriatr Soc. 2003;51:1125-30.
95. Stauffer BL, Hoetzer GL, Smith DT, DeSouza CA. Plasma C-reactive protein is not elevated in physically active postmenopausal women taking hormone replacement therapy. J Appl Physiol. 2004;96:143-8.
96. Colbert LH, Visser M, Simonsick EM, Tracy RP, Newman AB, Kritchevsky SB, Pahor M, Taaffe DR, Brach J, et al. Physical activity, exercise, and inflammatory markers in older adults: findings from the Health, Aging and Body Composition Study. J Am Geriatr Soc. 2004;52:1098-104.
97. King DE, Carek P, Mainous III, AG, Pearson WS. Inflammatory markers and exercise: differences related to exercise type. Med Sci Sports Exerc. 2003;35:575-81.
98. Pischon T, Hankinson SE, Hotamisligil GS, Rifai N, Rimm EB. Leisure-time physical activity and reduced plasma levels of obesity-related inflammatory markers. Obes Res. 2003;11:1055-64.
99. Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, Giugliano D. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA. 2003;289:1799-804.
100. Mattusch F, Dufaux B, Heine O, Mertens I, Rost R. Reduction of the plasma concentration of C-reactive protein following nine months of endurance training. Int J Sports Med. 2000;21:21-4.
101. Wegge JK, Roberts CK, Ngo TH, Barnard RJ. Effect of diet and exercise intervention on inflammatory and adhesion molecules in postmenopausal women on hormone replacement therapy and at risk for coronary artery disease. Metabolism. 2004;53:377-81.
102. Nicklas BJ, Ambrosius W, Messier SP, Miller GD, Penninx BW, Loeser RF, Palla S, Bleecker E, Pahor M. Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clinical trial. Am J Clin Nutr. 2004;79:544-51.
103. Rauramaa R, Halonen P, Vaisanen SB, Lakka TA, Schmidt-Trucksass A, Berg A, Penttila IM, Rankinen T, Bouchard C. Effects of aerobic physical exercise on inflammation and atherosclerosis in men: the DNASCO Study: a six-year randomized, controlled trial. Ann Intern Med. 2004;140:1007-14.
104. Rawson ES, Freedson PS, Osganian SK, Matthews CE, Reed G, Ockene IS. Body mass index, but not physical activity, is associated with C-reactive protein. Med Sci Sports Exerc. 2003;35:1160-6.
105. Ryan AS, Berman DM, Nicklas BJ, Sinha M, Gingerich RL, Meneilly GS, Egan JM, Elahi D. Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care. 2003;26:2383-8.
106. Blum CA, Muller B, Huber P, Kraenzlin M, Schindler C, De Geyter C, Keller U, Puder JJ. Low-grade inflammation and estimates of insulin resistance during the menstrual cycle in lean and overweight women. J Clin Endocrinol Metab. 2005;90:3230-5.
107. Ryan AS, Nicklas BJ, Berman DM, Elahi D. Adiponectin levels do not change with moderate dietary induced weight loss and exercise in obese postmenopausal women. Int J Obes Relat Metab Disord. 2003;27:1066-71.
108. Steffes MW, Gross MD, Schreiner PJ, Yu X, Hilner JE, Gingerich R, Jacobs DR, Jr. Serum adiponectin in young adults-interactions with central adiposity, circulating levels of glucose, and insulin resistance: the CARDIA study. Ann Epidemiol. 2004;14:492-8.
109. Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M, Nagai M, Matsuzawa Y, Funahashi T. Adiponectin as a biomarker of the metabolic syndrome. Circ J. 2004;68:975-81.
110. Jakobisiak M, Lasek W, Golab J. Natural mechanisms protecting against cancer. Immunol Lett. 2003;90:103-22.
111. Fairey AS, Courneya KS, Field CJ, Mackey JR. Physical exercise and immune system function in cancer survivors. Cancer. 2002;94:539-51.
112. Bonnet F, Lewden C, May T, Heripret L, Jougla E, Bevilacqua S, Costagliola D, Salmon D, Chene G, Morlat P. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer. 2004;101:317-24.
113. Herida M, Mary-Krause M, Kaphan R, Cadranel J, Poizot-Martin I, Rabaud C, Plaisance N, Tissot-Dupont H, Boue F, et al. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol. 2003;21:3447-53.
114. Shephard RJ, Shek PN. Cancer, immune function, and physical activity. Can J Appl Physiol. 1995;20:1-25.
115. Nieman DC. Exercise immunology: practical applications. Int J Sports Med. 1997;18: Suppl 1:S91-100.
116. Woods JA, Davis JM, Smith JA, Nieman DC. Exercise and cellular innate immune function. Med Sci Sports Exerc. 1999;31:57-66.
117. Shephard RJ, Verde TJ, Thomas SG, Shek P. Physical activity and the immune system. Can J Sport Sci. 1991;16:169-85.
118. Nieman DC. Risk of upper respiratory tract infection in athletes: an epidemiologic and immunologic perspective. J Athl Train. 1997;32:344-9.
119. Tanaka S, Inoue S, Isoda F, Waseda M, Ishihara M, Yamakawa T, Sugiyama A, Takamura Y, Okuda K. Impaired immunity in obesity: suppressed but reversible lymphocyte responsiveness. Int J Obes Relat Metab Disord. 1993;17:631-6.
120. Weber DJ, Rutala WA, Samsa GP, Bradshaw SE, Lemon SM. Impaired immunogenicity of hepatitis B vaccine in obese persons. N Engl J Med. 1986;314:1393.
121. Nieman DC, Henson DA, Nehlsen-Cannarella SL, Ekkens M, Utter AC, Butterworth DE, Fagoaga OR. Influence of obesity on immune function. J Am Diet Assoc. 1999;99:294-9.
122. Nieman DC, Nehlsen-Cannarella SI, Henson DA, Butterworth DE, Fagoaga OR,Warren BJ, Rainwater MK. Immune response to obesity and moderate weight loss. Int J Obes Relat Metab Disord. 1996;20:353-60.
123. Williams MT, Hord NG. The role of dietary factors in cancer prevention: beyond fruits and vegetables. Nutr Clin Pract. 2005;20:451-9.
124. Key TJ, Schatzkin A, Willett WC, Allen NE, Spencer EA, Travis RC. Diet, nutrition and the prevention of cancer. Public Health Nutr. 2004;7:187-200.
125. Prentice RL, Caan B, Chlebowski RT, Patterson R, Kuller LH, Ockene JK, Margolis KL, Limacher MC, Manson JE, et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006;295:629-42.
126. Beresford SA, Johnson KC, Ritenbaugh C, Lasser NL, Snetselaar LG, Black HR, Anderson GL, Assaf AR, Bassford T, et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006;295:643-54.
127. Eliassen AH, Colditz GA, Rosner B, Willett WC, Hankinson SE. Adult weight change and risk of postmenopausal breast cancer. JAMA. 2006;296:193-201.
128. Friedenreich CM, Orenstein MR. Physical activity and cancer prevention: etiologic evidence and biological mechanisms. J Nutr. 2002;132:3456S-64S.
129. Lee IM. Physical activity and cancer prevention-data from epidemiologic studies. Med Sci Sports Exerc. 2003;35:1823-7.
130. Irwin ML, Yasui Y, Ulrich CM, Bowen D, Rudolph RE, Schwartz RS, Yukawa M, Aiello E, Potter JD, McTiernan A. Effect of exercise on total and intra-abdominal body fat in postmenopausal women: a randomized controlled trial. JAMA. 2003;289:323-30.
131. McTiernan A, Tworoger SS, Ulrich CM, Yasui Y, Irwin ML, Rajan KB, Sorensen B, Rudolph RE, Bowen D, et al. Effect of exercise on serum estrogens in postmenopausal women: a 12-month randomized clinical trial. Cancer Res. 2004;64:2923-8.
132. McTiernan A, Tworoger SS, Rajan KB, Yasui Y, Sorenson B, Ulrich CM, Chubak J, Stanczyk FZ, Bowen D, et al. Effect of exercise on serum androgens in postmenopausal women: a 12-month randomized clinical trial. Cancer Epidemiol Biomarkers Prev. 2004;13:1099-105.
133. McTiernan A, Sorensen B, Yasui Y, Tworoger SS, Ulrich CM, Irwin ML, Rudolph RE, Stanczyk FZ, Schwartz RS, Potter JD. No effect of exercise on insulin-like growth factor 1 and insulin-like growth factor binding protein 3 in postmenopausal women: a 12-month randomized clinical trial. Cancer Epidemiol Biomarkers Prev. 2005;14:1020-1.
134. Frank LL, Sorensen BE, Yasui Y, Tworoger SS, Schwartz RS, Ulrich CM, Irwin ML, Rudolph RE, Rajan KB, et al. Effects of exercise on metabolic risk variables in overweight postmenopausal women: a randomized clinical trial. Obes Res. 2005;13:615-25.
135. McTiernan A, Yasui Y, Sorensen BE, Irwin ML, Morgan A, Rudolph RE, Surawicz C, Lampe LW, Ayub K, et al. Effect of a 12-month exercise intervention on patterns of cellular proliferation in colonic crypts: A randomized controlled trial. Cancer Epidemiol Biomarkers Prev. 2006;15:1588-97.
136. McTiernan A, Sorensen B, Irwin ML, Morgan A, Yasui Y, Rudolph RE, Surawicz C, Lampe LW, Lampe PD, et al. Exercise effect on weight and body fat in men and women. Obesity, in press.
137. Calle EE, Thun MJ. Obesity and cancer. Oncogene. 2004;23:6365-78.
138. McTiernan A, Slattery ML. Body size, obesity and colorectal cancer. In: McTiernan, A., editor. Cancer prevention and management through exercise and weight control. Boca Raton: CRC Press; 2006.
139. van den Brandt PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, Folsom AR, Fraser G, Goldbohm RA, Graham S, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol. 2000;152:514-27.
140. Patel AV, Bernstein L. Physical activity and cancer incidence: Breast cancer. In: McTiernan, A., editor. Cancer prevention and management through exercise and weight control. Boca Raton: CRC Press; 2006.
141. Kaaks R, Lukanova A. Endogenous hormone metabolism and endometrial cancer. In: McTiernan, A., editor. Cancer prevention and
142. management through exercise and weight control. Boca Raton: CRC Press; 2006.
143. Hoyo C, Gammon MD. Obesity and overweight in relation to adenocarcinoma of the esophagus. In: McTiernan, A., editor. Cancer prevention and management through exercise and weight control. Boca Raton: CRC Press; 2006.
144. The ALPHA Trial (Alberta Physical Activity and Breast Cancer Prevention Trial) [homepage on the Internet] [cited 2006 Aug 4]. Detailed study description. Available at: http://www.cancerboard.ab.ca/alphatrial/detailed. html.
145. Fred Hutchinson Cancer Research Center [homepage on the Internet]. The NEW study: Nutrition and Exercise for Women. c2006 [cited 2006 Aug 4]. Available at: http://www.fhcrc.org/science/phs/NEW/.
146. University of Minnesota [homepage on the Internet]. WISER: Women in Steady Exercise Research. [updated 2006 Jul 13; cited 2006 Aug 4]. Available at: http://www.wiserwomen.umn.edu/.
147. National Cancer Institute [homepage on the Internet]. Transdisciplinary Research on Energetics and Cancer (TREC) Centers. [cited 2006 Aug 4]. Available at: http://cancercontrol.cancer.gov/TREC/.
148. McTiernan A. Physical activity intervention studies in humans. In: McTiernan, A., editor. Cancer prevention and management through exercise and weight control. Boca Raton: CRC Press; 2006.